Financials
- Market Capitalization 349.93 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.11
Relación precio/flujo de caja
9 792.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3119 | CTNM Contineum Therapeutics, Inc. - Common stock | 16.07 USD | -1.05% | -4.40% | +5.58% | +5.24% | 371.20 M USD | ||
| 3126 | IPSC Century Therapeutics, Inc. - Common Stock | 2.01 USD | -1.95% | -8.64% | -1.95% | +310.20% | 363.96 M USD | ||
| 3188 | AGEN Agenus Inc. - Common Stock | 7.71 USD | +1.31% | -6.20% | +0.78% | +86.68% | 347.11 M USD | ||
| 3189 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.39 USD | +0.63% | -6.17% | -0.47% | +11.91% | 344.59 M USD |